COFCO Biotechnology Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 9,145.25 million compared to CNY 10,501.44 million a year ago. Revenue was CNY 9,310.07 million compared to CNY 10,609.26 million a year ago.

Net loss was CNY 335.24 million compared to net income of CNY 785.92 million a year ago. Basic loss per share from continuing operations was CNY 0.1833 compared to basic earnings per share from continuing operations of CNY 0.4234 a year ago. Diluted loss per share from continuing operations was CNY 0.1833 compared to diluted earnings per share from continuing operations of CNY 0.4234 a year ago.